High Glucose-induced Oxidative Stress Increases Transient Receptor Potential Channel Expression in Human Monocytes
Overview
Affiliations
Objective: Transient receptor potential (TRP) channel-induced cation influx activates human monocytes, which play an important role in the pathogenesis of atherosclerosis. In the present study, we investigated the effects of high glucose-induced oxidative stress on TRP channel expression in human monocytes.
Research Design And Methods: Human monocytes were exposed to control conditions (5.6 mmol/l d-glucose), high glucose (30 mmol/l d-glucose or l-glucose), 100 micromol/l peroxynitrite, or high glucose in the presence of the superoxide dismutase mimetic tempol (100 micromol/l). TRP mRNA and TRP protein expression was measured using quantitative real-time RT-PCR and quantitative in-cell Western assay, respectively. Calcium influx and intracellular reactive oxygen species were measured using fluorescent dyes.
Results: Administration of high d-glucose significantly increased reactive oxygen species. High d-glucose or peroxynitrite significantly increased the expression of TRP canonical type 1 (TRPC1), TRPC3, TRPC5, TRPC6, TRP melastatin type 6 (TRPM6), and TRPM7 mRNA and TRPC3 and TRPC6 proteins. High d-glucose plus tempol or high l-glucose did not affect TRP expression. Increased oxidative stress by lipopolysaccharide or tumor necrosis factor-alpha increased TRP mRNA expression, whereas the reduction of superoxide radicals using diphenylene iodonium significantly reduced TRP mRNA expression. Increased TRPC3 and TRPC6 protein expression was accompanied by increased 1-oleoyl-2-acetyl-sn-glycerol-induced calcium influx, which was blocked by the TRPC inhibitor 2-aminoethoxydiphenylborane. TRPC6 mRNA was significantly higher in monocytes from 18 patients with type 2 diabetes compared with 28 control subjects (P < 0.05).
Conclusions: High d-glucose-induced oxidative stress increases TRP expression and calcium influx in human monocytes, pointing to a novel pathway for increased activation of monocytes and hence atherosclerosis in patients with diabetes.
Boda V, Yasmen N, Jiang J, Li W Med Res Rev. 2024; 44(6):2510-2544.
PMID: 38715347 PMC: 11452291. DOI: 10.1002/med.22048.
Hu F, Lin C Mol Cell Biochem. 2024; 479(12):3307-3328.
PMID: 38308007 PMC: 11511773. DOI: 10.1007/s11010-024-04926-0.
Luo Z, Zhang Y, Saleh Q, Zhang J, Zhu Z, Tepel M Front Immunol. 2023; 14:1278560.
PMID: 37868998 PMC: 10588449. DOI: 10.3389/fimmu.2023.1278560.
Okada Y, Numata T, Sabirov R, Kashio M, Merzlyak P, Sato-Numata K Front Cell Dev Biol. 2023; 11:1246955.
PMID: 37842082 PMC: 10576435. DOI: 10.3389/fcell.2023.1246955.
Zheng Y, Huang Q, Zhang Y, Geng L, Wang W, Zhang H Front Immunol. 2023; 14:1237992.
PMID: 37705977 PMC: 10497121. DOI: 10.3389/fimmu.2023.1237992.